Lam Research (LRCX) is advancing 4% after investment bank Cantor Fitzgerald issued a bullish note on the shares. Cantor reiterated a $100 price target and an Overweight rating on the name.

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

This discipline includes fundamental research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to these agents.

Samsung Electronics Co. Ltd.-1.71% ₩389.41T ...

View Lam Research Corporation (LRCX) current and estimated P/E ratio data provided by Seeking Alpha.